Showing 1 posts of 1 posts found.
Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement